75/100B47.010
USD
0.10
(0.21%)
Pre Open·48.030USD+1.020(+2.17%)
Last updated: · Delayed 15 min
Fair value82.55Plus-43%62Price 47.01103
Q4 FY2026 · Earnings report
EPS estimate 0.96Revenue estimate 14.41B
Q4 FY2026 · Earnings report
EPS estimate 0.96Revenue estimate 14.41B
Sanofi ADS debt to equity ratioWhat is the debt to equity ratio? Debt to equity is a company's total debt divided by its shareholders' equity: how much it has borrowed for each dollar its owners have in the business.
Sanofi ADS's debt to equity ratio is 0.27: total debt of 19.85B EUR against shareholders' equity of 72.88B EUR.
- Today
- 0.27
- Average, 5 years
- 0.22
- Low, 5 years
- 0.00
- High, 5 years
- 0.34
Debt to equity = total debt ÷ shareholders' equity = 19.85B ÷ 72.88B = 0.27
Debt to equity
Total debt
Shareholders' equity
Total debt over shareholders' equity at each quarter end.
Debt to equity by year and by quarter
| Fiscal year | Period ending | Debt to equity | Total debt | Shareholders' equity |
|---|---|---|---|---|
| Today | 0.27 | 19.85B | 72.88B | |
| FY2025 | 31 Dec 2025 | 0.28 | 20.33B | 71.38B |
| FY2024 | 31 Dec 2024 | 0.23 | 17.91B | 77.51B |
| FY2023 | 31 Dec 2023 | 0.25 | 18.70B | 74.04B |
| FY2022 | 31 Dec 2022 | 0.28 | 21.21B | 74.78B |
| FY2021 | 31 Dec 2021 | 0.33 | 22.41B | 68.68B |
| FY2020 | 31 Dec 2020 | 0.38 | 23.68B | 63.11B |
| FY2019 | 31 Dec 2019 | 0.44 | 25.93B | 58.93B |
| FY2018 | 31 Dec 2018 | 0.42 | 24.64B | 58.88B |
| FY2017 | 31 Dec 2017 | 0.27 | 15.60B | 58.07B |
| FY2016 | 31 Dec 2016 | 0.32 | 18.58B | 57.55B |
| FY2015 | 31 Dec 2015 | 0.29 | 16.55B | 58.05B |
| FY2014 | 31 Dec 2014 | 0.26 | 14.81B | 56.12B |
| FY2013 | 31 Dec 2013 | 0.26 | 14.59B | 56.90B |
| FY2012 | 31 Dec 2012 | 0.25 | 14.53B | 57.33B |
| FY2011 | 31 Dec 2011 | 0.27 | 15.44B | 56.20B |
| FY2010 | 31 Dec 2010 | 0.16 | 8.26B | 53.10B |
| FY2009 | 31 Dec 2009 | 0.18 | 8.83B | 48.19B |
| FY2008 | 31 Dec 2008 | 0.13 | 6.01B | 44.87B |
| FY2007 | 31 Dec 2007 | 0.13 | 5.94B | 44.54B |
| FY2006 | 31 Dec 2006 | 0.15 | 6.94B | 45.60B |
| FY2005 | 31 Dec 2005 | 0.24 | 11.18B | 46.13B |
| FY2004 | 31 Dec 2004 | 0.39 | 16.04B | 41.06B |
| FY2003 | 31 Dec 2003 | 0.06 | 367.64M | 6.31B |
| FY2002 | 31 Dec 2002 | 0.07 | 416.45M | 6.04B |
| FY2001 | 31 Dec 2001 | 0.07 | 404.00M | 5.77B |
| FY2000 | 31 Dec 2000 | 0.10 | 412.00M | 4.30B |
| FY1999 | 31 Dec 1999 | 0.13 | 461.00M | 3.58B |
| Quarter | Period ending | Debt to equity | Total debt | Shareholders' equity |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 0.27 | 19.85B | 72.88B |
| Q2 FY2026 | 30 Jun 2026 | 0.34 | 23.58B | 69.21B |
| Q1 FY2026 | 31 Mar 2026 | 0.27 | 20.02B | 72.81B |
| Q4 FY2025 | 31 Dec 2025 | 0.28 | 20.33B | 71.38B |
| Q3 FY2025 | 30 Sept 2025 | 0.30 | 21.76B | 73.26B |
| Q2 FY2025 | 30 Jun 2025 | 0.32 | 22.29B | 70.01B |
| Q1 FY2025 | 31 Mar 2025 | 0.28 | 21.05B | 74.07B |
| Q4 FY2024 | 31 Dec 2024 | 0.23 | 17.91B | 77.51B |
| Q3 FY2024 | 30 Sept 2024 | — | — | — |
| Q2 FY2024 | 30 Jun 2024 | 0.33 | 24.03B | 72.69B |
| Q1 FY2024 | 31 Mar 2024 | 0.00 | 0.00 | 74.35B |
| Q4 FY2023 | 31 Dec 2023 | 0.25 | 18.70B | 74.04B |
| Q3 FY2023 | 30 Sept 2023 | 0.00 | 0.00 | 72.95B |
| Q2 FY2023 | 30 Jun 2023 | 0.29 | 21.03B | 72.63B |
| Q1 FY2023 | 31 Mar 2023 | 0.00 | 0.00 | 75.15B |
| Q4 FY2022 | 31 Dec 2022 | 0.28 | 21.21B | 74.78B |
| Q3 FY2022 | 30 Sept 2022 | 0.00 | 0.00 | 71.30B |
| Q2 FY2022 | 30 Jun 2022 | 0.30 | 21.24B | 70.95B |
| Q1 FY2022 | 31 Mar 2022 | 0.00 | 0.00 | 69.03B |
| Q4 FY2021 | 31 Dec 2021 | 0.33 | 22.41B | 68.68B |
| Q3 FY2021 | 30 Sept 2021 | 0.00 | 0.00 | 63.36B |
| Q2 FY2021 | 30 Jun 2021 | 0.34 | 21.65B | 63.24B |
| Q1 FY2021 | 31 Mar 2021 | 0.00 | 0.00 | 63.15B |
| Q4 FY2020 | 31 Dec 2020 | 0.38 | 23.68B | 63.00B |
| Q3 FY2020 | 30 Sept 2020 | 0.00 | 0.00 | 63.49B |
| Q2 FY2020 | 30 Jun 2020 | 0.39 | 24.93B | 63.30B |
| Q1 FY2020 | 31 Mar 2020 | 0.00 | 0.00 | 59.11B |
| Q4 FY2019 | 31 Dec 2019 | 0.44 | 25.93B | 58.93B |
| Q3 FY2019 | 30 Sept 2019 | 0.00 | 0.00 | 56.52B |
| Q2 FY2019 | 30 Jun 2019 | 0.47 | 26.70B | 56.35B |
| Q1 FY2019 | 31 Mar 2019 | 0.00 | 0.00 | 59.04B |
| Q4 FY2018 | 31 Dec 2018 | 0.42 | 24.64B | 58.88B |
| Q3 FY2018 | 30 Sept 2018 | 0.00 | 0.00 | 56.36B |
| Q2 FY2018 | 30 Jun 2018 | 0.51 | 28.94B | 56.20B |
| Q1 FY2018 | 31 Mar 2018 | 0.46 | 27.00B | 58.09B |
| Q4 FY2017 | 31 Dec 2017 | 0.27 | 15.60B | 58.09B |
| Q3 FY2017 | 30 Sept 2017 | 0.00 | 0.00 | 57.79B |
| Q2 FY2017 | 30 Jun 2017 | 0.32 | 18.43B | 57.63B |
| Q1 FY2017 | 31 Mar 2017 | 0.00 | 0.00 | 57.72B |
| Q4 FY2016 | 31 Dec 2016 | 0.32 | 18.58B | 57.55B |
| Q3 FY2016 | 30 Sept 2016 | 0.00 | 0.00 | 54.35B |
| Q2 FY2016 | 30 Jun 2016 | 0.32 | 17.28B | 54.19B |
| Q1 FY2016 | 31 Mar 2016 | 0.00 | 0.00 | 58.21B |
| Q4 FY2015 | 31 Dec 2015 | 0.29 | 16.55B | 58.05B |
| Q3 FY2015 | 30 Sept 2015 | 0.00 | 0.00 | 56.77B |
| Q2 FY2015 | 30 Jun 2015 | 0.26 | 14.73B | 56.62B |
| Q1 FY2015 | 31 Mar 2015 | 0.00 | 0.00 | 56.27B |
| Q4 FY2014 | 31 Dec 2014 | 0.26 | 14.81B | 56.12B |
| Q3 FY2014 | 30 Sept 2014 | 0.00 | 0.00 | 51.77B |
| Q2 FY2014 | 30 Jun 2014 | 0.29 | 14.80B | 51.64B |
| Q1 FY2014 | 31 Mar 2014 | 0.00 | 0.00 | 57.01B |
| Q4 FY2013 | 31 Dec 2013 | 0.26 | 14.59B | 56.90B |
| Q3 FY2013 | 30 Sept 2013 | 0.00 | 0.00 | 56.20B |
| Q2 FY2013 | 30 Jun 2013 | 0.26 | 14.66B | 56.07B |
| Q1 FY2013 | 31 Mar 2013 | 0.00 | 0.00 | 57.47B |
| Q4 FY2012 | 31 Dec 2012 | 0.25 | 14.53B | 57.33B |
| Q3 FY2012 | 30 Sept 2012 | — | — | — |
| Q2 FY2012 | 30 Jun 2012 | 0.29 | 16.18B | 56.21B |
| Q1 FY2012 | 31 Mar 2012 | — | — | — |
| Q4 FY2011 | 31 Dec 2011 | 0.27 | 15.44B | 56.19B |
| Q3 FY2011 | 30 Sept 2011 | — | — | — |
| Q2 FY2011 | 30 Jun 2011 | 0.38 | 20.04B | 52.46B |
| Q1 FY2011 | 31 Mar 2011 | — | — | — |
| Q4 FY2010 | 31 Dec 2010 | 0.16 | 8.26B | 53.10B |
| Q3 FY2010 | 30 Sept 2010 | — | — | — |
| Q2 FY2010 | 30 Jun 2010 | 0.18 | 9.57B | 52.42B |
| Q1 FY2010 | 31 Mar 2010 | — | — | — |
| Q4 FY2009 | 31 Dec 2009 | 0.18 | 8.83B | 48.32B |
| Q3 FY2009 | 30 Sept 2009 | — | — | — |
| Q2 FY2009 | 30 Jun 2009 | 0.22 | 9.92B | 44.62B |
| Q1 FY2009 | 31 Mar 2009 | — | — | — |
| Q4 FY2008 | 31 Dec 2008 | 0.13 | 6.01B | 44.87B |
| Q3 FY2008 | 30 Sept 2008 | — | — | — |
| Q2 FY2008 | 30 Jun 2008 | 0.16 | 6.54B | 41.39B |
| Q1 FY2008 | 31 Mar 2008 | — | — | — |
| Q4 FY2007 | 31 Dec 2007 | 0.13 | 5.94B | 44.54B |
| Q3 FY2007 | 30 Sept 2007 | — | — | — |
| Q2 FY2007 | 30 Jun 2007 | 0.14 | 6.66B | 46.02B |
| Q1 FY2007 | 31 Mar 2007 | — | — | — |
| Q4 FY2006 | 31 Dec 2006 | 0.15 | 6.94B | 45.60B |
| Q3 FY2006 | 30 Sept 2006 | — | — | — |
| Q2 FY2006 | 30 Jun 2006 | 0.22 | 9.95B | 45.04B |
| Q1 FY2006 | 31 Mar 2006 | — | — | — |
| Q4 FY2005 | 31 Dec 2005 | 0.24 | 11.17B | 46.09B |
| Q3 FY2005 | 30 Sept 2005 | — | — | — |
| Q2 FY2005 | 30 Jun 2005 | 0.34 | 15.01B | 44.10B |
| Q1 FY2005 | 31 Mar 2005 | — | — | — |
| Q4 FY2004 | 31 Dec 2004 | 0.39 | 16.03B | 41.03B |
| Q3 FY2004 | 30 Sept 2004 | — | — | — |
| Q2 FY2004 | 30 Jun 2004 | 0.05 | 323.02M | 6.83B |
| Q1 FY2004 | 31 Mar 2004 | — | — | — |
| Q4 FY2003 | 31 Dec 2003 | 0.06 | 367.64M | 6.31B |
| Q3 FY2003 | 30 Sept 2003 | — | — | — |
| Q2 FY2003 | 30 Jun 2003 | 0.05 | 306.80M | 5.58B |
| Q1 FY2003 | 31 Mar 2003 | — | — | — |
| Q4 FY2002 | 31 Dec 2002 | 0.07 | 416.45M | 6.04B |
| Q3 FY2002 | 30 Sept 2002 | — | — | — |
| Q2 FY2002 | 30 Jun 2002 | 0.08 | 451.96M | 5.90B |
Figures in EUR. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:P/E ratio,Market cap,P/S ratio,ROE (return on equity),Current ratio,All ratios
Common questions about Sanofi ADS's debt to equity
Source: Financial Modeling Prep